Click here to go to the previous page
The Importance of Rh Variants and Molecular Typing in Hemolytic Transfusion Reactions in Sickle Cell Disease
Program Code:
9418-TC
Date:
Tuesday, October 9, 2012
Time:
2:00 PM to 3:30 PM
EST
SPEAKER
(S):
France Noizat-Pirenne, MD, PhD, Medical Director and Scientific Director, Etablissement Franais du Sang, Ile de France
Stella Chou, MD, Assistant Professor of Pediatrics, The Children's Hospital of Philadelphia
Dr. Karen King, MD, Director of Hemapheresis and Transfusion Support; Assoc Dir of Transfusion Medicine, Johns Hopkins Medical Institutions
Description
Disparities in red cell antigen expression between donors and recipients with sickle cell disease contribute to high rates of alloimmunization and hemolytic transfusion reactions in this population. In this session, international and national perspectives on the clinical relevance of Rh variants and molecular typing programs by blood collection and hospital services to improve care for people with sickle cell disease will be presented. Unique aspects of hemolytic transfusion reactions in sickle cell disease, such as hyperhemolysis, will also be discussed.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.